Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06773897 · ClinicalTrials.gov registry record
Rutgers University Study of the Genetics of Breast Cancer.
A clinical trial of Breast Cancer and Breast Cancer Risk, sponsored by Rutgers, The State University of New Jersey.
- Recruiting
- Registry status
- 25,000
- Enrollment target
- 1
- Study location
NCT06773897 is a study of Breast Cancer and Breast Cancer Risk that is actively recruiting participants, run by Rutgers, The State University of New Jersey. The registered enrollment target is 25,000 participants, above the 2,783-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (798% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06773897, a study of Breast Cancer and Breast Cancer Risk, is actively recruiting participants, sponsored by Rutgers, The State University of New Jersey.
- RECRUITING
- Registry status
- 25,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this observational study is to learn more about how genes impact the risk of breast cancer. Anyone 18 or older living in the US is eligible, and a diagnosis of cancer is NOT required. Study participation is online, and it takes about 20 minutes to complete health surveys and request a saliva collection kit sent through US mail. In return, study participants may opt to receive information about their genetic ancestry at no cost.
Conditions Studied
Interventions
- GENETIC Saliva sample
- OTHER Health Surveys
Study Locations (1)
New Jersey
- Rutgers University - Piscataway
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25,000 participants |
| Start Date | 2024-04-15 |
| Est. Completion | 2027-04-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06773897
The ClinicalTrials.gov registry entry for NCT06773897 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 25,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 2,783-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (798% higher). The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which Saliva sample is the first listed.
NCT06773897 reports 1 study location spanning 1 distinct geographic area - top geographies include New Jersey.
Frequently Asked Questions
What is clinical trial NCT06773897 about?
NCT06773897 is a clinical study titled "Rutgers University Study of the Genetics of Breast Cancer.". The goal of this observational study is to learn more about how genes impact the risk of breast cancer. Anyone 18 or older living in the US is eligible, and a diagnosis of cancer is NOT required. Study participation is online, and it takes about 20 minutes to complete health surveys and request a sa...
What is the current status of trial NCT06773897?
This trial is currently recruiting. The enrollment target is 25,000 participants. The study started on 2024-04-15. Estimated completion is 2027-04-30.
What conditions does trial NCT06773897 study?
This clinical trial studies the following conditions: Breast Cancer, Breast Cancer Risk, Breast Cancer Prevention.
What interventions are being tested in trial NCT06773897?
The interventions under investigation include: Saliva sample (GENETIC), Health Surveys (OTHER).
Who is sponsoring clinical trial NCT06773897?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06773897 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Surviving Daily Life
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.